Mehmet Ali Uzun
Mehmet Ali Uzun has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Sevcan Alkan Kayaoglu
Haydarpasa Numune Training and Research Hospital, Turkey
4 shared publications - Aylin Gönültaş
Pathology, Çorlu State Hospital, Tekirdağ, Turkey
2 shared publications - Doğan Erdoğan
SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, İSTANBUL HAYDARPAŞA NUMUNE SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ
2 shared publications - Gülten Çiçek Okuyan
Department of General Surgery, Haydarpasa Numune Education and Training Hospital, Istanbul, Turkey
2 shared publications - Metin Tilki
Department of General Surgery, Haydarpasa Numune Training and Research Hospital, University of Health Sciences, Istanbul, Turkey
2 shared publications - Ahmet Çoker
Clinic of General Surgery, Medicana International İzmir Hospital, İzmir, Türkiye
1 shared publication
Latest Publications
- Open Access
- 9 September 2024
- Published by Ege Journal of Medicine in Ege Tıp Dergisi
- Vol. 63 (3) , 356-361
Is circular-stapled gastrojejunostomy anastomosis apppropriate for pancreaticoduodenectomy?
INTRODUCTION:Pancreaticoduodenectomy is a highly complex procedure that requires surgical experience.. Among these is the use of a stapler in the construction of the gastrojejunostomy anastomosis during the procedure. Our study compares the patient outcomes of gastrojejunostomy anastomosis procedures performed manually and with a circular stapler. MATERIALS AND METHOD:Our study retrospectively evaluated the data of 44 patients who had undergone pancreaticoduodenectomy performed by the same surgical team between May 2015 and December 2019. The manual gastrojejunostomy anastomosis(n = 32) and stapled (circular stapler 25 millimeter) anastomosis(n=12) patient groups were compared for anastomotic stricture. RESULTS:Of the 44 patients undergoing pancreaticoduodenectomy, 68.2% were male, the mean age was 62.9±12.1 years and the mean follow-up was 28.2±21.2 months. The rate of gastrojejunostomy stricture was significantly higher in the circular stapler group (p = 0.017;p < 0.05). CONCLUSION:The increased risk of postoperative pancreatic fistula and anastomotic stricture prevents us from recommending the use of a circular-stapler in the creation of the gastrojejunostomy anastomosis in pancreaticoduodenectomy procedures, as it increases the risk of postoperative pancreatic fistula and anastomotic stricture, and provides no operative time advantage.
- 9 September 2024
- Published by Ege Journal of Medicine in Ege Tıp Dergisi
- Vol. 63 (3) , 356-361
Open AccessIs circular-stapled gastrojejunostomy anastomosis apppropriate for pancreaticoduodenectomy?
INTRODUCTION:Pancreaticoduodenectomy is a highly complex procedure that requires surgical experience.. Among these is the use of a stapler in the construction of the gastrojejunostomy anastomosis during the procedure. Our study compares the patient outcomes of gastrojejunostomy anastomosis procedures performed manually and with a circular stapler. MATERIALS AND METHOD:Our study retrospectively evaluated the data of 44 patients who had undergone pancreaticoduodenectomy performed by the same surgical team between May 2015 and December 2019. The manual gastrojejunostomy anastomosis(n = 32) and stapled (circular stapler 25 millimeter) anastomosis(n=12) patient groups were compared for anastomotic stricture. RESULTS:Of the 44 patients undergoing pancreaticoduodenectomy, 68.2% were male, the mean age was 62.9±12.1 years and the mean follow-up was 28.2±21.2 months. The rate of gastrojejunostomy stricture was significantly higher in the circular stapler group (p = 0.017;p < 0.05). CONCLUSION:The increased risk of postoperative pancreatic fistula and anastomotic stricture prevents us from recommending the use of a circular-stapler in the creation of the gastrojejunostomy anastomosis in pancreaticoduodenectomy procedures, as it increases the risk of postoperative pancreatic fistula and anastomotic stricture, and provides no operative time advantage.
- Open Access
- 20 June 2024
- Published by Annali Italiani di Chirurgia in Annali Italiani di Chirurgia
- Vol. 95 (3) , 411-415
Omental Flap Technique in Pancreaticojejunostomy: Does it Prevent Pancreatic Fistula Development after Pancreaticoduodenectomy?
AIM: The aim of our study was to investigate the clinical results of omental flap application during pancreaticojejunostomy (PJ) anastomosis in pancreatoduodenectomy (PD) surgeries. METHODS: The data of patients who underwent pancreaticoduodenectomy in our hospital were evaluated retrospectively. The patients were divided into two groups; patients with an omental flap (Group 1) and those without an omental flap (Group 2). The demographic and other characteristics of the groups and the incidence of postoperative pancreatic fistula (POPF) development were compared. RESULTS: One hundred patients were included (39 females, 61 males) Group 1 consisted of 20 patients with omental flaps and Group 2 consisted of 80 patients without omental flaps. While no clinically significant (Grade B and C) leaks were observed in Group 1, both biochemical and clinically significant leak rates were lower in Group 1 compared to 4 patients (5%) in Group 2. There was no statistically significant difference compared with Group 2 (p > 0.05). CONCLUSIONS: Although not statistically significant in this study, postoperative complication rates and the incidence of POPF tended to decrease in patients who underwent omental flaps.
- 20 June 2024
- Published by Annali Italiani di Chirurgia in Annali Italiani di Chirurgia
- Vol. 95 (3) , 411-415
Open AccessOmental Flap Technique in Pancreaticojejunostomy: Does it Prevent Pancreatic Fistula Development after Pancreaticoduodenectomy?
AIM: The aim of our study was to investigate the clinical results of omental flap application during pancreaticojejunostomy (PJ) anastomosis in pancreatoduodenectomy (PD) surgeries. METHODS: The data of patients who underwent pancreaticoduodenectomy in our hospital were evaluated retrospectively. The patients were divided into two groups; patients with an omental flap (Group 1) and those without an omental flap (Group 2). The demographic and other characteristics of the groups and the incidence of postoperative pancreatic fistula (POPF) development were compared. RESULTS: One hundred patients were included (39 females, 61 males) Group 1 consisted of 20 patients with omental flaps and Group 2 consisted of 80 patients without omental flaps. While no clinically significant (Grade B and C) leaks were observed in Group 1, both biochemical and clinically significant leak rates were lower in Group 1 compared to 4 patients (5%) in Group 2. There was no statistically significant difference compared with Group 2 (p > 0.05). CONCLUSIONS: Although not statistically significant in this study, postoperative complication rates and the incidence of POPF tended to decrease in patients who underwent omental flaps.
- Open Access
- 1 December 2022
- Published by Turkish Journal of Surgery in Turkish Journal of Surgery
- Vol. 38 (4) , 334-344
Long-term results and prognostic factors after surgical treatment for gallbladder cancer
Objective: Gallbladder cancer is relatively rare and traditionally regarded as having poor prognosis. There is controversy about the effects of clinicopathological features and different surgical techniques on prognosis. The aim of this study was to investigate the effects of clinicopathological characteristics of the patients with surgically treated gallbladder cancer on long-term survival. Material and Methods: We retrospectively analyzed the database of gallbladder cancer patients treated at our clinic between January 2003 and March 2021. Results: Of 101 evaluated cases, 37 were inoperable. Twelve patients were determined unresectable based on surgical findings. Resection with curative intent was performed in 52 patients. The one-, three-, five-, and 10-year survival rates were 68.9%, 51.9%, 43.6%, and 43.6%, respectively. Median survival was 36.6 months. On univariate analysis, poor prognostic factors were determined as advanced age; high carbohydrate antigen 19-9 and carcinoembryonic antigen levels; non-incidental diagnosis; intraoperative incidental diagnosis; jaundice; adjacent organ/structure resection; grade 3 tumors; lymphovascular invasion; and high T, N1 or N2, M1, and high AJCC stages. Sex, IVb/V segmentectomy instead of wedge resection, perineural invasion, tumor location, number of resected lymph nodes, and extended lymphadenectomy did not significantly affect overall survival. On multivariate analysis, only high AJCC stages, grade 3 tumors, high carcinoembryonic antigen levels, and advanced age were independent predictors of poor prognosis. Conclusion: Treatment planning and clinical decision-making for gallbladder cancer requires individualized prognostic assessment along with standard anatomical staging and other confirmed prognostic factors.
- 1 December 2022
- Published by Turkish Journal of Surgery in Turkish Journal of Surgery
- Vol. 38 (4) , 334-344
Open AccessLong-term results and prognostic factors after surgical treatment for gallbladder cancer
Objective: Gallbladder cancer is relatively rare and traditionally regarded as having poor prognosis. There is controversy about the effects of clinicopathological features and different surgical techniques on prognosis. The aim of this study was to investigate the effects of clinicopathological characteristics of the patients with surgically treated gallbladder cancer on long-term survival. Material and Methods: We retrospectively analyzed the database of gallbladder cancer patients treated at our clinic between January 2003 and March 2021. Results: Of 101 evaluated cases, 37 were inoperable. Twelve patients were determined unresectable based on surgical findings. Resection with curative intent was performed in 52 patients. The one-, three-, five-, and 10-year survival rates were 68.9%, 51.9%, 43.6%, and 43.6%, respectively. Median survival was 36.6 months. On univariate analysis, poor prognostic factors were determined as advanced age; high carbohydrate antigen 19-9 and carcinoembryonic antigen levels; non-incidental diagnosis; intraoperative incidental diagnosis; jaundice; adjacent organ/structure resection; grade 3 tumors; lymphovascular invasion; and high T, N1 or N2, M1, and high AJCC stages. Sex, IVb/V segmentectomy instead of wedge resection, perineural invasion, tumor location, number of resected lymph nodes, and extended lymphadenectomy did not significantly affect overall survival. On multivariate analysis, only high AJCC stages, grade 3 tumors, high carcinoembryonic antigen levels, and advanced age were independent predictors of poor prognosis. Conclusion: Treatment planning and clinical decision-making for gallbladder cancer requires individualized prognostic assessment along with standard anatomical staging and other confirmed prognostic factors.
- Open Access
- 29 June 2022
- Published by Galenos Yayinevi in Turkish Journal of Surgery
- Vol. 38 (2) , 101-120
Turkish HPB Surgery Association consensus report on hepatic cystic Echinococcosis (HCE)
Objective: Cystic Echinococcosis (CE) is one of the important problems of the Eurasian region. We aimed to prepare a consensus report in order to update the treatment approaches of this disease. This study was conducted by Turkish HPB Surgery Association. Material and Methods: This study was conducted with the modified Delphi model. For this purpose, we conducted a three-stage consensus-building approach. Results: Six topics, including diagnosis, medical treatment, percutaneous treatment, surgical treatment, management of complications and posttreatment follow-up and recurrences in HCE were discussed. Conclusion: The expert panel made recommendations for every topic.
- 29 June 2022
- Published by Galenos Yayinevi in Turkish Journal of Surgery
- Vol. 38 (2) , 101-120
Open AccessTurkish HPB Surgery Association consensus report on hepatic cystic Echinococcosis (HCE)
Objective: Cystic Echinococcosis (CE) is one of the important problems of the Eurasian region. We aimed to prepare a consensus report in order to update the treatment approaches of this disease. This study was conducted by Turkish HPB Surgery Association. Material and Methods: This study was conducted with the modified Delphi model. For this purpose, we conducted a three-stage consensus-building approach. Results: Six topics, including diagnosis, medical treatment, percutaneous treatment, surgical treatment, management of complications and posttreatment follow-up and recurrences in HCE were discussed. Conclusion: The expert panel made recommendations for every topic.
- Open Access
- 1 May 2022
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 68 (5) , 664-669
Is the tumor-stroma ratio a prognostic factor in gallbladder cancer?
OBJECTIVE: This study aimed to examine the prognostic effect of the tumor-stroma ratio, which has been shown to have prognostic value in various cancers, in patients with gallbladder cancer who have undergone curative resection. METHODS: The records of gallbladder cancer patients who underwent surgical treatment in our clinic between December 2005 and March 2021 were analyzed retrospectively. The hematoxylin and eosin-stained sections representing the tumors were evaluated under light microscopy to determine tumor-stroma ratio, and based on the results, <50% was defined as the stroma-rich and ???50% as the stroma-poor groups. RESULTS: A total of 28 patients, including 20 females and 8 males, with a mean age of 64.6 years, were included in this study. Stroma-poor and stromarich tumors were detected in 15 and 13 patients, respectively. There was no statistically significant relationship identified between tumor-stroma ratio and advanced age, gender, serum levels of carbohydrate antigen 19-9 and carcinoembryonic antigen, incidental or nonincidental diagnosis, jaundice, adjacent organ or structure resection, tumor location, grades 1???2 or 3, T1/T2 or T3/T4, N0 or N1/N2, M stage, American Joint Committee on Cancer stage, lymphovascular invasion, and perineural invasion. The stroma-poor and stroma-rich groups had a 5-year survival rate of 30% and 19.2% and a median overall survival of 25.7 and 15.1 months, respectively, with no statistically significant difference between the groups (p=0.526). CONCLUSIONS: A low tumor-stroma ratio tended to be a poor prognostic factor in gallbladder cancer, although not to a statistically significant degree. This can be considered one of the preliminary studies, as further studies involving larger groups are needed.
- 1 May 2022
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 68 (5) , 664-669
Open AccessIs the tumor-stroma ratio a prognostic factor in gallbladder cancer?
OBJECTIVE: This study aimed to examine the prognostic effect of the tumor-stroma ratio, which has been shown to have prognostic value in various cancers, in patients with gallbladder cancer who have undergone curative resection. METHODS: The records of gallbladder cancer patients who underwent surgical treatment in our clinic between December 2005 and March 2021 were analyzed retrospectively. The hematoxylin and eosin-stained sections representing the tumors were evaluated under light microscopy to determine tumor-stroma ratio, and based on the results, <50% was defined as the stroma-rich and ???50% as the stroma-poor groups. RESULTS: A total of 28 patients, including 20 females and 8 males, with a mean age of 64.6 years, were included in this study. Stroma-poor and stromarich tumors were detected in 15 and 13 patients, respectively. There was no statistically significant relationship identified between tumor-stroma ratio and advanced age, gender, serum levels of carbohydrate antigen 19-9 and carcinoembryonic antigen, incidental or nonincidental diagnosis, jaundice, adjacent organ or structure resection, tumor location, grades 1???2 or 3, T1/T2 or T3/T4, N0 or N1/N2, M stage, American Joint Committee on Cancer stage, lymphovascular invasion, and perineural invasion. The stroma-poor and stroma-rich groups had a 5-year survival rate of 30% and 19.2% and a median overall survival of 25.7 and 15.1 months, respectively, with no statistically significant difference between the groups (p=0.526). CONCLUSIONS: A low tumor-stroma ratio tended to be a poor prognostic factor in gallbladder cancer, although not to a statistically significant degree. This can be considered one of the preliminary studies, as further studies involving larger groups are needed.
- 7 July 2021
- Published by Kahramanmaras Sutcu Imam Universitesi Tip Fakultesi Dergisi in Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi
- Vol. 16 (2) , 143-148
AKUT PANKREATİTİN ŞİDDETİNİ ÖNGÖRMEDE YATAK BAŞI AKUT PANKREATİT ŞİDDET İNDEKS SKORU İLE APACHE II SKORUNUN KARŞILAŞTIRILMASI
AMAÇ: AP pankreasın akut inflamatuar bir hastalığıdır. Hastaların çoğunda hafif seyrederken, yaklaşık %10-20’sinde şiddetli seyredip ciddi morbidite ve mortalite riski taşır. Şiddetli AP hastalarının, uygun merkezlerde ve gereğinde yoğun bakım ünitelerinde yapılan erken agresif tedavisi ile morbidite ve mortalite düşürülebilmekte olup AP şiddetini erken ve güvenilir bir şekilde ön görebilmek önemlidir. GEREÇ VE YÖNTEMLER: Bu çalışmada, AP şiddetini öngörmede BISAP skoru ile APACHE II skorunun karşılaştırılması amaçlandı. Bu amaçla mart 2015 - temmuz 2016 arasında tedavi ettiğimiz 86 AP hastası çalışmaya alındı. Hastaların ortalama yaşı 52,33 olup 48’i (%55,8) kadındı. Revize Atlanta kriterlerine göre 58 (%67,4) hastada hafif, 20 (%23,3) hastada orta şiddette ve 8 (%9,3) hastada şiddetli AP saptandı. Şiddetli AP olan bir hasta eksitus oldu. Genel mortalite %1,16 ve şiddetli AP için mortalite %12,5 idi. BULGULAR:Hastalar başvuruda, 24. saat ve 48. saatte APACHE II ve ilk 24 saatte BISAP skorlaması ile değerlendirildi. BISAP skorlamasında ≥2 olan 11 (%12,8) hastanın 5’i (%45,45) şiddetli AP, 5’i orta şiddette AP ve 1’ide (%9,09) hafif AP idi. BISAP skoru <2 olan 75 hastanın ise sadece 3’ünde (%4) şiddetli AP saptandı. Başvuruda APACHE II skoru ≥8 olan 9 (%10,5) hastanın 6’sı (%66,7) şiddetli AP, 3’ü ise orta şiddette AP idi. Skoru <8 olan 77 hastanın ise sadece 3’ünde (%2,6) şiddetli AP saptandı. 24. ve 48. saat APACHE II skoru ≥8 olan 4 hastanın (%4,7) tamamı şiddetli AP idi. Şiddetli AP gelişmesinin BISAP ile öngörülmesinde duyarlılık %62,50; özgüllük % 92,31; pozitif prediktif değer %45,45 ve negatif prediktif değer %96 olarak saptandı. Şiddetli AP gelişmesinin APACHE II ile öngörülmesinde; başvurudaki APACHE II için duyarlılık %75; özgüllük % 96,15; pozitif prediktif değer %66,67 ve negatif prediktif değer %97,40 iken 24. saat ve 48. saat APACHE II için duyarlılık %50; özgüllük % 100; pozitif prediktif değer %100 ve negatif prediktif değer %95,12 olarak saptandı. SONUÇLAR: Çalışmamızda AP’in şiddetini öngörmede BISAP skorlaması ile gerek başvuruda gerekse 24. ve 48. saat APACHE II skorlamaları arasında istatistiksel anlamlı pozitif korelasyon saptandı. Etkinlikleri değerlendirildiğinde de benzer doğrulukta oldukları görüldü. Sonuç olarak; BISAP skorlamasının AP şiddetini öngörmede, uygulaması zor ve karmaşık bir yöntem olan APACHE II skorlaması yerine daha kolay ve basit bir yöntem olarak uygulanabileceğini düşünmekteyiz.
- 7 July 2021
- Published by Kahramanmaras Sutcu Imam Universitesi Tip Fakultesi Dergisi in Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi
- Vol. 16 (2) , 143-148
AKUT PANKREATİTİN ŞİDDETİNİ ÖNGÖRMEDE YATAK BAŞI AKUT PANKREATİT ŞİDDET İNDEKS SKORU İLE APACHE II SKORUNUN KARŞILAŞTIRILMASI
AMAÇ: AP pankreasın akut inflamatuar bir hastalığıdır. Hastaların çoğunda hafif seyrederken, yaklaşık %10-20’sinde şiddetli seyredip ciddi morbidite ve mortalite riski taşır. Şiddetli AP hastalarının, uygun merkezlerde ve gereğinde yoğun bakım ünitelerinde yapılan erken agresif tedavisi ile morbidite ve mortalite düşürülebilmekte olup AP şiddetini erken ve güvenilir bir şekilde ön görebilmek önemlidir. GEREÇ VE YÖNTEMLER: Bu çalışmada, AP şiddetini öngörmede BISAP skoru ile APACHE II skorunun karşılaştırılması amaçlandı. Bu amaçla mart 2015 - temmuz 2016 arasında tedavi ettiğimiz 86 AP hastası çalışmaya alındı. Hastaların ortalama yaşı 52,33 olup 48’i (%55,8) kadındı. Revize Atlanta kriterlerine göre 58 (%67,4) hastada hafif, 20 (%23,3) hastada orta şiddette ve 8 (%9,3) hastada şiddetli AP saptandı. Şiddetli AP olan bir hasta eksitus oldu. Genel mortalite %1,16 ve şiddetli AP için mortalite %12,5 idi. BULGULAR:Hastalar başvuruda, 24. saat ve 48. saatte APACHE II ve ilk 24 saatte BISAP skorlaması ile değerlendirildi. BISAP skorlamasında ≥2 olan 11 (%12,8) hastanın 5’i (%45,45) şiddetli AP, 5’i orta şiddette AP ve 1’ide (%9,09) hafif AP idi. BISAP skoru <2 olan 75 hastanın ise sadece 3’ünde (%4) şiddetli AP saptandı. Başvuruda APACHE II skoru ≥8 olan 9 (%10,5) hastanın 6’sı (%66,7) şiddetli AP, 3’ü ise orta şiddette AP idi. Skoru <8 olan 77 hastanın ise sadece 3’ünde (%2,6) şiddetli AP saptandı. 24. ve 48. saat APACHE II skoru ≥8 olan 4 hastanın (%4,7) tamamı şiddetli AP idi. Şiddetli AP gelişmesinin BISAP ile öngörülmesinde duyarlılık %62,50; özgüllük % 92,31; pozitif prediktif değer %45,45 ve negatif prediktif değer %96 olarak saptandı. Şiddetli AP gelişmesinin APACHE II ile öngörülmesinde; başvurudaki APACHE II için duyarlılık %75; özgüllük % 96,15; pozitif prediktif değer %66,67 ve negatif prediktif değer %97,40 iken 24. saat ve 48. saat APACHE II için duyarlılık %50; özgüllük % 100; pozitif prediktif değer %100 ve negatif prediktif değer %95,12 olarak saptandı. SONUÇLAR: Çalışmamızda AP’in şiddetini öngörmede BISAP skorlaması ile gerek başvuruda gerekse 24. ve 48. saat APACHE II skorlamaları arasında istatistiksel anlamlı pozitif korelasyon saptandı. Etkinlikleri değerlendirildiğinde de benzer doğrulukta oldukları görüldü. Sonuç olarak; BISAP skorlamasının AP şiddetini öngörmede, uygulaması zor ve karmaşık bir yöntem olan APACHE II skorlaması yerine daha kolay ve basit bir yöntem olarak uygulanabileceğini düşünmekteyiz.